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Background: Bacteria need iron from the host to establish infection.
Results: We report the first structure of hemoglobin bound to a bacterial protein and show that targeted disruption of this
interaction can reduce Staphylococcus aureus growth when hemoglobin is the sole iron source.
Conclusion: Physical capture of hemoglobin is important for iron uptake by S. aureus.
Significance: Hemoglobin receptors may be targets for new antibacterial agents.
Pathogens must steal iron from their hosts to establish infec-
tion. In mammals, hemoglobin (Hb) represents the largest res-
ervoir of iron, and pathogens express Hb-binding proteins to
access this source. Here, we show how one of the commonest
and most significant human pathogens, Staphylococcus aureus,
captures Hb as the first step of an iron-scavenging pathway. The
x-ray crystal structure of Hb bound to a domain from the Isd
(iron-regulated surface determinant) protein, IsdH, is the first
structure of a Hb capture complex to be determined. Surface
mutations in Hb that reduce binding to the Hb-receptor limit
the capacity of S. aureus to utilize Hb as an iron source, suggest-
ing that Hb sequence is a factor in host susceptibility to infec-
tion. The demonstration that pathogens make highly specific
recognition complexes withHb raises the possibility of develop-
ing inhibitors of Hb binding as antibacterial agents.
Bacteria that cause human disease must acquire iron from
their host to establish infection (1). Host strategies to restrict
iron availability therefore constitute a formof innate immunity.
Most iron is sequestered within cells, and serum iron is kept at
an extremely low concentration (1024 M) by the iron trans-
port protein transferrin (2). A related protein, lactoferrin, is
present in exocrine solutions such as tears and milk and is also
released from neutrophils at sites of infection (3). Iron uptake
and homeostasis are even tuned toward anemia in chronic
infection by the hormone hepcidin (4). In cases where serum
iron levels are either artificially or genetically elevated, there are
dramatic increases in levels of bacteremia (5).
Bacteria in all iron-restricted environments, including the
human body, employ a variety of generic mechanisms to scav-
enge this essential element. Thesemechanisms include the pro-
duction of siderophores, small (typically1000Da) soluble fac-
tors that bind with very high affinity (1022–1050 M) to
Fe(III). Siderophores are subsequently reabsorbed by the bac-
teria in the iron-charged form (6). Alternatively, iron-reducing
compounds can be released into the environment to generate
soluble Fe(II) that is absorbed through the FeoB permease,
escaping the requirement for metabolically expensive sidero-
phore production (7).
Naturally, the rich iron reservoirs found in mammals and
other animals has driven evolution of iron-scavenging mecha-
nisms that are specific to the pathogen-host relationship. Per-
haps the most distinguishing feature of the mammalian iron
profile is that75% of the total body-iron is locked up in heme,
a cyclic organic compound (porphyrin) with central square-
planar Fe(II/III) ion coordinated by four nitrogen atoms. This
iron pool is considered largely inaccessible to siderophores (6),
and pathogens have therefore evolved specialized pathways
dedicated to heme uptake. As with all forms of iron, heme is
retained tightly sequestered into host proteins at all times.Hb is
the most abundant heme protein in humans, accounting for
70% of total body iron, making it a particularly attractive iron
source for invading microbes.
Highly pathogenic species such as Staphylococcus aureus
secrete hemolysins (8) to release Hb into the serum where it is
accessible to the bacteria. S. aureus displays a preference for
heme as an iron source (9) and can grow on Hb as the sole
source of iron (10, 11). Utilization ofHb in S. aureus ismediated
by Isd proteins (12, 13), which are also found in a large number
of other Gram-positive pathogens (14, 15). The Isd pathway in
S. aureus comprises nine proteins IsdA-I (12).Of these, the four
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proteins IsdA, IsdB, IsdC, and IsdH are expressed on the bac-
terial cell-surface, anchored through a C-terminal covalent
linkage to the peptidoglycan cell wall. Notably, the surface
exposed Isd proteins are the most highly up-regulated genes in
response to iron starvation in S. aureus (16) and Bacillus
anthracis (17). IsdB and IsdH are Hb-binding proteins (10, 11).
IsdA and IsdC are heme-binding proteins that cooperate with
IsdB/H through an unknown mechanism to transfer heme in a
unidirectional manner to the membrane-associated lipopro-
tein IsdE (18–20). A dedicated ABC transporter complex (IsdD
and IsdF) transfers heme from IsdE into the S. aureus cyto-
plasm, where the porphyrin macrocycle is cleaved by a heme
oxygenase complex (IsdG and IsdI), releasing its iron (21).
Genetic inactivation of IsdA (22), IsdB (11, 22, 23), IsdH (24,
25), IsdG, or IsdI (26) reduces the ability of S. aureus to cause
infections in mice, confirming the Isd system as an important
virulence mechanism. It has been demonstrated that immuni-
zation with IsdA, IsdB or IsdH antigens (24, 25, 27–29) or
administration of purified antibodies to IsdA, IsdB, IsdC, and
IsdH (22) confers some protection from infection in various
animal models. These studies suggest that blocking the Isd
pathway of heme/iron uptake could have therapeutic benefit in
human infections.
To transfer the heme group from Hb to the bacterial mem-
brane, the cell wall-anchored proteins IsdA, IsdB, IsdC, and
IsdH each possess one 130-residue NEAT (near iron trans-
porter) domain that binds to heme (30–34). Extraction of heme
from Hb relies upon a physical interaction of Hb with the Hb
receptors IsdB and IsdH (20). IsdB and IsdH contain, respec-
tively, one or two variantNEATdomains that possessHb-bind-
ing activity but do not bind to heme (see Fig. 1A) (10, 35–37).
The structural basis for heme binding by NEAT domains is
comparatively well understood (30–34), but the molecular
mechanism of Hb recognition has remained elusive and is the
subject of the current investigation.
Many pathogens express Hb-binding proteins, but the
molecular details underlying Hb recognition are unknown in
every case. Here, we show that the first NEAT domain from
IsdH (IsdHN1) binds to a site on the -chain of Hb (Hb) and
determine the x-ray crystal structure of the IsdHN1Hb com-
plex. Using mutant forms of Hb that are defective in IsdHN1
binding, we demonstrate that physical capture of Hb by
S. aureus is important for the utilization of this iron source.
EXPERIMENTAL PROCEDURES
Protein Preparation—The DNA sequence encoding the
IsdHN1 (IsdH residues 86–229) and IsdHN2 (residues 321–467)
domains from S. aureus strain TCH1516 were cloned into
pET15b (Novagen) for expression with an N-terminal His6 tag.
The proteins were expressed and purified as described previ-
ously (35) to yield a final product with the additional N-termi-
nal sequence MGSSHHHHHHSSGLVPRGSHM. Native
human Hb A was prepared and separated into its constituent
HbandHbchains as described previously (38).Hb,Hb, and
Hb were maintained in the carbonmonoxy-liganded state
during purification and subsequent analysis, unless otherwise
specified.
Recombinant human Hb (rhHb)5 was produced in Esche-
richia coli strain BL21(DE3) from the pHb0.0 plasmid, a gift of
Dr. John Olson (39). pHUG21 (a gift of Dr. Doug Henderson)
harboring the Plesiomonas shigelloides heme transport system
was co-transformed to enhance rHb expression (40). The
heme transport system was induced by iron restriction with 50
g/ml of the iron chelator ethylenediamine-di-(o-hydroxyphe-
nyl acetic acid) (EDDHA, LGC Standards GmbH). rHb expres-
sion was performed at 16 °C overnight, and bacteria were lysed
by passage through a French press twice at 1200 psi. Hb was
purified in a single step over nickel-nitrilotriacetic acid beads
(Qiagen) by virtue of interactions with naturally occurring His
residues on the surface of Hb and dialyzed twice against PBS.
Substitution mutations within the Hb genes were generated
using PCR-based mutagenesis and confirmed by sequencing.
For protein crystallography, native Hb purified in the car-
bonmonoxy-liganded state was converted to the oxygenated
form by passing a pure stream of oxygen over a protein solution
held on ice and illuminated with a focused beam from a 50-watt
halogen lamp. The oxy-Hb was converted to met-Hb by addi-
tion of excess potassium ferricyanide in 20 mM sodium phos-
phate, pH 7.0. The reaction was monitored to completion by
UV-visible spectroscopy, at which point the Hb protein was
isolated over SephadexG-25.Met-Hbwas combinedwith puri-
fied IsdHN1 in a 1:1 molar ratio (with respect to HbHb
dimers) for crystallization.
Light Scattering—Samples were separated on a Superose 12
column (GE Healthcare) equilibrated in 20 mM sodium phos-
phate, 150 mM sodium chloride, pH 7.0, with in-line MALS
(mini-DAWN; Wyatt Technology Corp., Santa Barbara, CA)
and refractive index (Optilab differential refractometer, Wyatt
Technology Corp.) measurements. The refractive index incre-
ment with respect to mass concentration (dn/dc) was taken to
be 0.19 ml g1 for all proteins/complexes.
Isothermal Titration Calorimetry (ITC)—ITC was carried
out on a MicroCal iTC200 instrument. All components were
dialyzed into 20mM sodiumphosphate, pH 7.5, 150mM sodium
chloride. Multiple injections of 1.1 l were performed at 150-s
intervals, with continuous stirring at 20 °C. The volume of the
reaction cell was 350 l. Heats of dilution were determined
from injections of protein solution into buffer and subtracted
from the experimental data.
UV-visible Spectroscopy—Changes in heme coordination of
Hb (20 M) were measured by UV-visible absorption spec-
troscopy (Shimadzu UV1800) at 30 °C in the presence/absence
of NEAT domains in 20 mM sodium phosphate, 10 M diethyl-
enetriaminepenta-acetic acid, pH 7.0.
Structure Determination—Crystals were prepared by hang-
ing-drop vapor diffusion at 293 K inwhich 2l protein solution
(10.9 mg/ml) was mixed with 2 l of precipitant (0.2 M potas-
sium thiocyanate, 0.1 M Bis-tris propane, pH 7.5, 20% PEG).
Crystals of 150–200 m appeared within 2 days. Seeding was
done to grow diffraction quality crystals. The crystals were
5 The abbreviations used are: rhHb, recombinant human Hb; rHb, recombi-
nant Hb; ITC, isothermal titration calorimetry; PDB, Protein Data Bank;
EDDHA, ethylenediamine-di-(o-hydroxyphenyl acetic acid); SEC, size
exclusion chromatography.
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cryoprotected with 30% glycerol and flash-cooled in a cold
nitrogen stream (100 K). X-ray diffraction data were collected
in-house using copper K x-ray produced by a Rigaku 007HF
rotating-anode generator with Osmic Varimax optics and
recorded on a MAR345 image plate (Marresearch GmBH).
Data were collected over a phi-range of 180° and were
indexed and scaled using MOSFLM (41) and Scalepack (42).
Structure was solved by molecular replacement using PHASER
(43), which gave a unique solution when using Hb or Hb
(PDB code 1IRD) as independent search models. The structure
was refined using REFMAC5 (44), withmanual map inspection
and model building performed in COOT (45). The quality of
the model was regularly checked for steric clashes, incorrect
stereochemistry, and rotamer outliers using MolProbity (46).
Bacterial Strains and Growth Conditions—All experiments
were carried out with S. aureus strain Newman (47) or with
mutants generated in its background. All cultures were inocu-
lated from a single colony and grown overnight (20 h) in 5 ml
of RPMI medium (Thermo) supplemented with 1% casamino
acids in 15-ml conical tubes at 37 °C with shaking at 180 rota-
tions per minute (rpm). The isogenic variant in which the Hb
receptors IsdB and IsdH have been deleted (isdBH) has been
described previously (11).
S. aureus Growth Curves—Single colonies of S. aureus were
inoculated into RPMI medium plus casamino acids, supple-
mented with 0.5 mM EDDHA and grown overnight. One ml of
overnight cultures was normalized to A600 of 3.0, and bacteria
were sedimented (9000  g, 3 min) and resuspended in 1 ml of
NRPMIwith 0.5mMEDDHA.NRPMIwas prepared in advance
by treating RPMI plus casamino acids with Chelex 100 (Sigma)
according to themanufacturer’s recommendations and supple-
menting the resulting ion-deficientmediumwith 25mMZnCl2,
25 M MnCl2, 100 M CaCl2, and 1 M MgCl2. The resulting
suspension of S. aureus was subcultured (1:100) into 1 ml of
NRPMI with 0.5 mM EDDHA and rHb at 2.5 g/ml. One-ml
cultures were incubated at 37 °C in 15-ml conical tubes with
shaking at 180 rpm.A600 measurements were taken at the indi-
cated time points by mixing 20-l aliquots of the culture with
180 l of PBS in 96-well plates. The graphs represent a mean of
three independent experiments. Error bars represent S.D.;
asterisks denote values upon mutant rHb supplementation
significantly different from values upon wild type rHb supple-
mentation at the same time point (Student’s two-tailed t test,
p  0.05).
RESULTS
First and Second NEAT Domains of IsdH Bind to Hb Chain
of Hb—To investigate the molecular mechanism of Hb recog-
nition by S. aureus, we produced the Hb-binding domains,
IsdHN1 and IsdHN2 (Fig. 1A), in an E. coli expression system.
Recombinant IsdHN1 and IsdHN2 are pure monomers as deter-
mined by SEC (Fig. 1B) and Rayleigh light scattering (supple-
mental Table 1). Both NEAT domains bind to native adult Hb
A, shifting the SEC elution peak to an earlier elution time (Fig.
1C, solid line). Formation of a protein complex was confirmed
by light scattering measurements (supplemental Fig. 1). To
determine the binding sites on Hb, we first separated the con-
stituentHb andHb chains.Mixing of IsdHN1 or IsdHN2with
purified Hb, at a 1:1 molar ratio, lead to the formation of a
distinct protein complex (Fig. 1D), with a molecular weight
close to that expected for a heterodimer (supplemental Fig. 1).
The binding affinity for the IsdHN1:Hb was 100 nM, deter-
mined by isothermal titration calorimetry (ITC, supplemental
Fig. 2). Interaction between IsdHN1 and Hb could not be
detected using SEC (Fig. 1E), light scattering or ITC (supple-
mental Figs. 1 and 2). Some evidence of complex formation was
detected uponmixing equimolar quantities of IsdHN2 andHb,
but themixture retained a substantial proportion of freemono-
mers suggesting a weaker interaction (Fig. 1E). Thus, the
IsdHN1/N2 domains show a clear preference for Hb binding,
although it is conceivable that interaction of IsdHN2 with Hb
might also be significant in vivo. In the absence of heme, the
resulting apo-Hbchain is no longer competent to bind IsdHN1
(supplemental Fig. 3), suggesting that Hb is released from the
Hb receptor following heme removal.
IsdHN1/N2 Do Not Induce Large-scale Changes in Heme
Pocket Structure of Hb—To determine whether IsdHN1 or
IsdHN2 domains induce structural changes that might promote
heme release, we employed UV-visible absorption spectros-
FIGURE 1. The N-terminal NEAT domains of IsdH bind to Hb through the
Hb chain. A, the S. aureus Hb receptors IsdH and IsdB possess NEAT domains
that bind to Hb (stippled) or heme (gray). Amino acid sequence identity is
indicated for the pairs of NEAT domains joined by dashed lines. C-terminal
sortase cleavage sites are indicated. B, elution profiles of purified IsdHN1 and
IsdHN2 on SEC. C, SEC traces for free Hb A (dashed lines) or Hb A mixed with an
equimolar quantity of IsdHN1 or IsdHN2 (solid lines, equimolar with respect to
tetrameric HbA). A shift in the SEC elution peak to smaller elution volume
indicates the formation of a protein complex. D and E, SEC traces for Hb/Hb
alone (dashed lines) or mixed with an equimolar quantity of IsdHN1 or IsdHN2
(solid lines, equimolar with respect to Hb or Hb monomers). Refractometer
voltage is proportional to protein concentration. Light scattering data
accompanying B–E are shown in supplemental Fig. 1.
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copy as a sensitive probe of heme coordination chemistry.
These studies revealed that IsdHN1/N2 had no substantial effect
on Hb heme pocket structure or heme release over a period of
8 h (Fig. 2A). Small absorbance changes were observed in all
samples consistent with slow autooxidation. After 48 h the
spectrum of IsdHN1:Hb contained distinct peaks at 630, 500,
and 405 nm (Fig. 2B, solid line), characteristic of the auto-oxi-
dation product, met-Hb (48). The sample of free Hb con-
tained precipitate and following filtration, yielded a spectrum
indicative of a mixture of heme-ligand states (Fig. 2B, dashed
line). Our interpretation is that met-Hb forming in the free
Hb sample was being lost as precipitate (met-Hb is well
known to be highly unstable) and that IsdHN1 was stabilizing
met-Hb. ITC revealed that IsdHN1 binds carbonmonoxy-Hb
ormet-Hbwith the same affinity (supplemental Fig. 2). These
data indicate that IsdHN1 and IsdHN2 capture Hb, independent
of ligand/oxidation state, but do not induce conformational
changes in Hb that cause heme release. Hence, rapid heme
release must rely upon recruitment of the heme acceptor
domain of IsdH.
Crystal Structure of IsdHN1Hb Complex—To reveal the
molecularmechanismofHbbinding, IsdHN1was crystallized in
complexwithmet-Hb, and x-ray diffraction datawere collected
to a resolution of 3.0Å (Table 1). Initial phaseswere obtained by
molecular replacement using Hb or Hb (PDB code 1IRD) as
independent search models. In the crystal structure, IsdHN1
binds to one HbHb dimer through a site on the Hb chain
(Fig. 3A). There are two independent IsdHN1Hb complexes in
the crystallographic asymmetric unit. The IsdHN1 and Hb
subunits are identical in the two complexes (C coordinates
overlay with a root mean square displacement of 0.35 Å, sup-
plemental Fig. 4). Electron density in one of theHb subunits is
weak, possibly due to whole domain movement. The well
definedHbHbdimer is very similar in structure to the native
Hb dimer (C displacement of1 Å rootmean square) with no
dramatic conformational change being induced by IsdHN1
(supplemental Fig. 4). The dimeric form of Hb appears to have
been selected by the crystallization process, as IsdHN1 does not
overlap with the Hb dimer-tetramer interface. Indeed, molec-
ular weightmeasurements obtained for the complex in solution
were consistent with IsdHN1 bound to a mixture of Hb dimers
and tetramers (supplemental Table 1). In any case, the met-Hb
dimer-tetramer interaction is relativelyweak (Kd 30M) (49);
hence, theHbHbdimer observed in our structure is likely to
be a physiologically relevant species in plasma.
IsdHN1Hb Interface—The IsdHN1 domain is a nine-
stranded distorted -barrel with an immunoglobulin-like fold.
The conformation is very similar to the heme-binding NEAT
domains from IsdA, IsdB, and IsdC (30–34) but with an addi-
tional N-terminal helix loop. The binding site for Hb is formed
from loops at one end of the-barrel (Fig. 3A), designated loops
2, 4, 6, and 8 based on the conserved NEAT domain fold. Loop
2 of IsdHN1 contains an unusual string of five consecutive aro-
matic residues (Tyr-125, Tyr-126, His-127, Phe-128, and Phe-
129; Fig. 3, B and C), which are crucial for Hb binding (36). A
number of these aromatic side chains make van derWaals con-
tacts with non-polar surfaces onHb and are partially (Tyr-125
andPhe-128) or completely (Tyr-126 andPhe-129) buried from
solvent. Loops 4 and 6 of IsdHN1 account for the majority of
electrostatic interactions with Hb (Fig. 3C). Overall, the Hb-
interacting face of IsdHN1 displays a negative electrostatic
potential that complements a surface with positive potential on
Hb. Of particular note, the positively charged -amino group
of Hb Lys-11 protrudes into an electronegative pocket on
IsdHN1 (Fig. 3D) lined with hydroxyl and carbonyl groups from
Ser-130, Tyr-126, Asn-151, and Thr-152 (Fig. 3C).
A comparison with the NMR structure of the free IsdHN1
domain (Fig. 4, A and B) (36) reveals a substantial conforma-
tional change in IsdHN1 loops 2 and 8 upon complex formation.
Loop 8 requires a considerable movement of 8–10 Å to
accommodate Hb. More strikingly, residues 123–129 of loop
2 are disordered in free IsdHN1 (36) and undergo a transition to
an ordered helical conformation upon interaction with Hb. In
the absence of Hb, it appears that the aromatic side chains in
loop 2 cannot bury sufficient surface area to attain a stable fold.
In the helical conformation Gln-124 and His-127 in loop 2
make specific intramolecular H-bonding interactions with the
underlying -sheet (Fig. 4C). Remarkably, the Hb-binding site
on IsdHN1 occupies the same face of the NEAT fold that is used
to bind heme in other NEAT domains (Fig. 4D). We infer from
this that structural properties of the NEAT fold might predis-
pose this site to ligand interactions.
Mutations in Hb Abrogate Binding to IsdHN1/N2—To gain
insight into the ligand binding specificity of NEATdomains, we
compared the IsdHN1-binding surface of Hb (Fig. 5A) to the
surface ofHb, which does not bind IsdHN1 (Fig. 5B). Themost
outstanding difference between these two surfaces is a substi-
tution of Lys-11 in Hb and for Thr-12 in Hb. Interestingly,
Lys-11 is conserved across Hb sequences from distantly
relatedmammalian species (Fig. 5C). To test the role of Lys-11
FIGURE 2. Spectral analysis of the IsdHN1/N2Hb complexes. A, oxygen-
ated Hb was incubated with or without IsdHN1/N2 at 30 °C, and visible
absorption spectra were recorded at 0, 0.5, 1, 1.5, 2, 2.5, 3.5, 5.0, and 8.0 h.
Arrows indicate the direction of spectral change. B, after 48 h, the spectrum of
IsdHN1Hb contained peaks at 405, 500, and 630 nm, characteristic of
met-Hb.
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in IsdH recognition, we produced recombinant Hb (rHb)
carrying a Lys-11 to Thr mutation in the Hb chain
(rHb(K11T)). A second mutant (rHb(18,19)) was pro-
duced to test the effect of removing the binding site for one
of the IsdHN1 loop 2 aromatic residues (Tyr-125) by short-
ening the linker between Hb helices A and B. Thirdly,
rHb(A5E) was generated in response to the natural varia-
tion in this position across Hb sequences from different
TABLE 1
Crystallographic data collection and refinement statistics
Data collection
Space group P212121
Cell dimensions a  65.880, b  123.206, and c  143.933 Å;  , and  90°
Resolution (Å) 50.00–3.01 (3.16–3.01)
Rmerge 0.244 (0.785)
I/I 8.6 (2.3)












Root mean square deviations






FIGURE 3. The structure of the IsdHN1Hb complex. A, IsdHN1 (yellow) binds to the Hb subunit (orange) of the Hb:Hb dimer. B, stereo view of the 2Fo  Fc
electron density map contoured at 1 (mesh) for portions of IsdHN1 loop 2 (green), IsdHN1 loop 4 (cyan), and helix A of Hb (orange). C, aromatic residues from
IsdHN1 loop 2 (green) pack against Hb. Loops 4 and 6 of IsdHN1 (cyan) account for the majority of polar and H-bonding interactions (dashed lines). D, the
Hb-contacting surface of IsdHN1 colored by electrostatic potential (positive, blue; negative, red; supplemental “Experimental Procedures”) showing the
binding pocket for Hb Lys-11.
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species (Fig. 5C). Reciprocal mutations were also introduced
into the Hb chains (Fig. 5C).
Wild type and mutant rHb samples were purified and con-
verted to the stable cyanomet form (50). All proteins had nor-
mal UV-visible spectra (data not shown) and eluted in one
major peak from SEC, at the expected mobility (supplemental
Fig. 5), indicating no substantial defect in folding or Hb-Hb
subunit interactions. The individual SEC traces for rHb and
IsdHN1 are overlaid in Fig. 5D, upper panel. Mixing of these
components lead to formation of the expected IsdHN1Hb com-
plex (Fig. 5D, lower panel, black). Strikingly, rHb(K11T)
showed no detectable interaction with IsdHN1, yielding two
separate elution peaks (Fig. 5D, blue). Similarly, rHb(K11T)
failed to interact significantly with IsdHN2 (Fig. 5E, blue),
strongly suggesting that IsdHN1 and IsdHN2 bind a common
site on Hb. The reverse mutation in Hb, rHb(T12K), had no
detectable effect on IsdHN1 binding (Fig. 5D, red). However,
rHb(T12K) experienced a larger than normal shift in SEC
retention time when mixed with IsdHN2 (Fig. 5E, red), suggest-
ing that the intrinsic weak binding to wild type Hb subunits
might be enhanced by the T12K mutation. The A5E muta-
tion partially inhibited binding to IsdHN1 but not IsdHN2 and
rHb(G18,A19) also displayed reduced binding to IsdHN1 but
was not tested against IsdHN2 (Fig. 5F and supplemental Fig. 5).
In summary, both IsdHN1 and IsdHN2 are likely to bind Hb
through the same site on Hb but display some differences in
sequence specificity that could potentially provide greater tol-
erance to species variation in the Hb sequence.
IsdHN1-Hb Interaction Is Important for S. aureusGrowth on
Hb as Sole Iron Source—To investigate the importance of
NEAT-Hb interactions for iron uptake from Hb, we grew
S. aureus strain Newman onmedium containing Hb as the sole
iron source. When supplemented with rHb, a culture of
S. aureus grew over an incubation time of 40 h as shown in Fig.
5G (black). In contrast Hb carrying Hbmutations that inhibit
IsdHN1 and/or IsdHN2 binding supported a significantly slower
rate of culture growth. An S. aureus strain carrying deletions of
both Hb receptors, IsdB and IsdH (isdBH), failed to replicate
on wild type or mutant Hb (Fig. 5H), confirming that the
IsdB/H Hb receptors are required for iron uptake from Hb in
this assay. Compared with isdBH, the residual growth of
S. aureusNewman onmutant Hb suggested that our individual
Hbmutations are not sufficient to completely abrogate inter-
actions with intact IsdH and/or IsdB. This could be due to avid-
ity affects arising from the multidomain structure of IsdB/H,
binding of Hb through Hb chains, or because the mutations
that inhibit binding to IsdH have more limited effects on the
IsdB-Hb interaction. In any case, our results demonstrate that
capture ofHb throughNEATdomain receptors is an important
step that allows S. aureus to utilize iron from Hb.
DISCUSSION
Direct binding of host iron proteins to bacterial cell-surface
receptors is a widespread strategy to capture iron, but despite
their importance, these interactions are still poorly understood
at themolecular level. For example, the structures of transferrin
receptors present on the surface of pathogenic species from the
generaNeisseria and Pasteurella have only recently been deter-
mined (51, 52) and only then in the absence of the transferrin
ligand. The importance of Hb-binding proteins is emphasized
by their widespread distribution across bacterial and protozoan
pathogens. In Gram-negative bacteria, TonB-dependent heme
transporters in the bacterial outer membrane act as Hb recep-
tors in Haemophilus (53), Neisseria (54), Pasteurella (55), Por-
phyromonas (56), and Helicobacter (57) species. In Gram-pos-
itive bacteria, the IsdB/H proteins from S. aureus are the most
well documented Hb receptors, but cell-surface proteins from
Streptococcus pyogenes (58) Streptococcus equi (59) Bacillus
cereus (60), andCorynebacterium diphtheriae (61) are reported
to bind Hb. In addition to the surface-bound receptors,
secreted hemophores produced by Gram-negative (62) and
Gram-positive (63, 64) bacteria may transiently interact with
Hb to facilitate heme transfer. The IsdHN1met-Hb complex is
the first Hb receptor complex for which the structure has been
determined. It reveals a highly specific protein-protein interac-
tion, raising the possibility that inhibitors to this interaction
might be developed. If this is so, the diversity of Hb-binding
functions described above may provide restriction points
through which to inhibit colonization of the host by a range of
pathogens.
Loops 2 and 4 account for the majority of IsdHN1-Hb inter-
actions and are largely conserved in IsdHN2 and IsdBN1 (sup-
plemental Fig. 6), suggesting that all three NEAT domains bind
HbA in a similar way. In each case, loop 2 contains an aromatic-
FIGURE 4. The ligand-interaction sites in Hb-binding and heme-binding
NEAT domains share some common features. A, the NMR structure of free
IsdHN1 (PDB code 2H3K) contains a disordered loop 2 (36). B, when bound to
Hb, loop 2 of IsdHN1 adopts an -helical conformation. C, in the -helical
conformation, loop 2 makes H-bonding interactions with the underlying
-sheet. D, NEAT domains have evolved to bind Hb or heme ligands using a
similar face of the NEAT domain fold. Shown here, for comparison with
IsdHN1, is the heme-binding NEAT domain from IsdC in complex with Zn pro-
toporphyrin IX (PDB 2K78) (33). Green shading indicates regions that are
affected by conformational exchange in the ligand-free states of IsdHN1 and
IsdC.
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rich sequence and is predicted to adopt a similar -helical
structure, with conservedGln andHis residues interactingwith
the underlying -sheet (supplemental Fig. 6). In IsdHN1, Tyr-
126 and Ser-130 form part of the binding pocket for Hb Lys-
11, and these residues are conserved in IsdHN2 and IsdBN1.
Similarly, side chains from IsdHN1 loop 2 involved in H-bond-
ing to Lys-11 are conserved in IsdHN2 and IsdBN1. Thus, it is
likely that the preference for binding to Hb observed for
IsdHN1 and IsdHN2 will also hold true for IsdB. This, along with
the fact that Lys-11 is highly conserved in Hb sequences from
many mammalian species, argues that targeting the Hb sub-
unit is of mechanistic importance.
The transfer of heme from met-Hb to the isolated heme
acceptor domains of IsdH/B is governed by the simple dissoci-
ation of heme from met-Hb (20, 35) and is 2–3 orders of mag-
nitude slower than heme transfer to the full-lengthHb receptor
(20). Thus, physical interaction between Hb and the Hb recep-
tors is crucial for activating heme transfer. Structural and UV-
visible spectroscopy data obtained for IsdHN1/N2 argue that this
enhancement in heme transfer rate does not arise from a con-
FIGURE 5. Mutation of IsdH binding site in Hb restricts Hb utilization by S. aureus. A, the surface of Hb, colored by electrostatic potential (positive, blue;
negative, red) and Hb-contacting loops from IsdHN1 (same orientation as Fig. 3C). B, a model showing the surface of Hb (PDB 1GZX) overlaid with the
Hb-binding residues of IsdHN1. Dashed ovals mark substantial differences between the molecular surfaces of Hb and Hb. C, helix A sequences of Hb and
Hb from divergent mammalian species, showing Hb residues that make H-bonds (stars) or other contacts (dots) with IsdHN1. D, upper panel, SEC elution
traces for IsdHN1 (solid curve) and recombinant wild type Hb (rHb, dashed curve). Lower panel, SEC elution traces for mixtures of IsdHN1 with rHb (black),
rHb(T12K) (red), or rHb(K11T) (blue). E, SEC elution traces showing interactions of IsdHN2 with rHb and rHb mutants. F, summary of binding data for rHb
mutants, indicating the fraction of unbound IsdHN1 in chromatographic separations (supplemental Fig. 5). G, growth of S. aureus strain Newman with rHb or
rHb mutants as the sole iron source. H, growth of S. aureus isdBH under conditions as in G.
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formational change in Hb that promotes heme release. Instead,
we favor an alternative model whereby binding to Hb through
the IsdHN1/N2 or IsdBN1 domains enhances the rate of produc-
tive encounters between Hb chains and the IsdHN3 or IsdBN2
heme acceptor domains. One potential role for the specific
binding of IsdB/H to Hb subunits might be to control the
sequential release of heme from the Hb and Hb chains by
orienting the heme acceptor domains in a particular way.
HbHb dimers can loose heme from one subunit (semi-Hb)
and retainmuchof their native structure (65), potentially allow-
ing them to remain associated with theHb receptor until all the
heme is removed. IsdHN1 does not bind to free apo-Hb, sug-
gesting that the IsdHHb complex would dissociate following
complete heme removal from Hb.
NEAT domains with the characteristic aromatic loop 2
sequence of IsdHN1 are restricted to the genomes of S. aureus
and the related Staphylococcus lugdunensis, suggesting that the
Hb-binding mechanism described here is restricted to these
organisms. However, Hb-binding function has been reported
for other NEAT domain containing proteins, including IlsA
from B. cereus (60), IsdX1 from Bacillus anthrasis (63) and Shr
from S. pyogenes (66), suggesting that NEAT domains have
adapted to make different interactions with Hb or that
sequences outside the NEAT domains are responsible for the
Hb-binding activity of these proteins.
Concerted folding and binding is proposed to allow recogni-
tion of diverse molecular targets by a single protein (67), and it
is possible that, being an opportunistic pathogen, folding and
binding of IsdH might help S. aureus to accommodate some of
the natural sequence variation present in Hbs from different
host species. IsdH also binds directly to haptoglobin, a mam-
malian protein that is unrelated in sequence or structure to Hb
(10, 25, 35). Aromatic residues in IsdHN1 loop 2 are required for
binding toHbor haptoglobin (35), and it will nowbe interesting
to establish whether folding and binding has a role in accom-
modating these different ligands. The function of haptoglobin
is to sequester Hb that is released by continuous physiological
levels of hemolysis, hence the Hbhaptoglobin complex repre-
sents an alternative route through which S. aureus might cap-
ture Hb.
Among Isd proteins, folding and binding is not limited to
IsdH. AnNMR study of the heme-binding NEAT domain from
IsdC revealed that loop 2 (Fig. 4D) undergoes significant con-
formational dynamics in the absence of ligand (33) consistent
with a folding-and-binding event. Here, loop flexibility may
facilitate insertion of the hydrophobic heme molecule “under”
loop 2. In contrast, loop 2 from the heme-binding NEAT
domain of IsdA adopts a helical conformation in crystal struc-
tures of the heme-free and heme-bound forms. The structure of
IsdA has not been determined in solution, and it is conceivable
that a folded loop 2 conformation might be stabilized during
crystallization. Although a more extensive study into the gen-
eral role of conformational dynamics in NEAT-ligand interac-
tions is required, it is tempting to speculate that structural flex-
ibility in an ancestral NEAT domain may have played a role in
the remarkable adaptation of this domain to binding such vastly
different molecular targets as heme and Hb protein.
The IsdHN1Hb structure reveals a highly specific recogni-
tion interface that allows S. aureus to capture heme directly
from the richest iron source in the mammalian host. The Hb-
receptor mechanism establishes a direct conduit for the trans-
fer of heme groups from host Hb into the bacterial cytoplasm.
In this regard, it contrastswith strategies such as siderophore or
protease secretion, which mobilize iron into the extracellular
milieu where it can be intercepted by competing bacterial pop-
ulations. The highly specific nature of the IsdH-Hb interaction
suggests that sequence variation in the IsdB/H-binding face of
Hb could influence susceptibility to S. aureus infection, as
described recently for mice and humans (68). Determining the
structure of an Hb-capture complex now raises the exciting
possibility of mimicking the NEAT-interacting face of Hb as a
strategy for developing new anti-virulence treatments for
S. aureus infection.
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